Home

Quang X. Pham, Chairman, CEO and Interim CFO: Cadrenal Therapeutics CVKD Sell · Filed 06/18

Trade details

Type
Insider sale
Amount
$1,621.08
Shares · price
513 sh · $3.16 a share
Held after
128,589 sh
Trade date
26/06/17
Filed
26/06/18
Days to filing
1 days

Sold 0.4% of holdings

Share of holding sold
0.4%

Cadrenal Therapeutics trades, last 26 weeks

What else happened in Cadrenal Therapeutics around then

Filed or reported within 30 days of the trade day · 05/18~07/17

Quang X. Pham's recent trades

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $27.5K

    Filed 06/26

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $6,381

    Filed 06/26

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $32.5K

    Filed 06/24

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $7,286

    Filed 06/24

  • Quang X. Pham

    Sell10b5-1 planCadrenal Therapeutics

    $11.5K

    Filed 06/18

Quang X. Pham, Chairman — sold $1,621 of Cadrenal Therapeutics CVKD · 0.4% of holdings · 10b5-1 plan | Whalegun